# Christine M. Lovly

**Type:** Researchers  
**Canonical URL:** https://scholariq.org/researchers/christine-m-lovly/

## Facts

| Field | Value |
| --- | --- |
| Citations | 19,175 |
| Field | Lung Cancer Treatments and Mutations |
| h-index | 62 |
| i10-index | 138 |
| Last Known Institution | City Of Hope National Medical Center |
| OpenAlex ID | https://openalex.org/A5074068244 |
| ORCID iD | 0000-0002-3641-6361 |
| Works | 594 |

## Researcher papers

Showing 12 of 13.

- [<i>ROS1</i> Rearrangements Define a Unique Molecular Class of Lung Cancers](https://scholariq.org/papers/i-ros1-i-rearrangements-define-a-unique-molecular-class-of-lung-cancers/)
- [Non–Small Cell Lung Cancer, Version 3.2022, NCCN Clinical Practice Guidelines in Oncology](https://scholariq.org/papers/non-small-cell-lung-cancer-version-3-2022-nccn-clinical-practice-guidelines-in/)
- [Mechanisms of receptor tyrosine kinase activation in cancer](https://scholariq.org/papers/mechanisms-of-receptor-tyrosine-kinase-activation-in-cancer/)
- [NCCN Guidelines Insights: Non–Small Cell Lung Cancer, Version 2.2021](https://scholariq.org/papers/nccn-guidelines-insights-non-small-cell-lung-cancer-version-2-2021/)
- [Non–Small Cell Lung Cancer, Version 4.2024](https://scholariq.org/papers/non-small-cell-lung-cancer-version-4-2024/)
- [Mechanisms of acquired resistance to first- and second-generation EGFR tyrosine kinase inhibitors](https://scholariq.org/papers/mechanisms-of-acquired-resistance-to-first-and-second-generation-egfr-tyrosine/)
- [Melanoma-specific MHC-II expression represents a tumour-autonomous phenotype and predicts response to anti-PD-1/PD-L1 therapy](https://scholariq.org/papers/melanoma-specific-mhc-ii-expression-represents-a-tumour-autonomous-phenotype-and/)
- [Targeted Next Generation Sequencing Identifies Markers of Response to PD-1 Blockade](https://scholariq.org/papers/targeted-next-generation-sequencing-identifies-markers-of-response-to-pd-1/)
- [NCCN Guidelines® Insights: Non–Small Cell Lung Cancer, Version 2.2023](https://scholariq.org/papers/nccn-guidelines-insights-non-small-cell-lung-cancer-version-2-2023/)
- [Inflammatory Myofibroblastic Tumors Harbor Multiple Potentially Actionable Kinase Fusions](https://scholariq.org/papers/inflammatory-myofibroblastic-tumors-harbor-multiple-potentially-actionable/)
- [Integrative Analysis of a Large Real-World Cohort of Small Cell Lung Cancer Identifies Distinct Genetic Subtypes and Insights into Histologic Transformation](https://scholariq.org/papers/integrative-analysis-of-a-large-real-world-cohort-of-small-cell-lung-cancer-2/)
- [Integrative analysis of a large real-world cohort of small cell lung cancer identifies distinct genetic subtypes and insights into histological transformation](https://scholariq.org/papers/integrative-analysis-of-a-large-real-world-cohort-of-small-cell-lung-cancer/)

## Researcher topics

- [Lung Cancer Treatments and Mutations](https://scholariq.org/topics/lung-cancer-treatments-and-mutations/)
- [Lung Cancer Research Studies](https://scholariq.org/topics/lung-cancer-research-studies/)
- [Cancer Genomics and Diagnostics](https://scholariq.org/topics/cancer-genomics-and-diagnostics/)
- [Cancer therapeutics and mechanisms](https://scholariq.org/topics/cancer-therapeutics-and-mechanisms/)
- [RNA modifications and cancer](https://scholariq.org/topics/rna-modifications-and-cancer/)

## Researcher university

- [City Of Hope National Medical Center](https://scholariq.org/institutions/city-of-hope-national-medical-center/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.